Skip to search formSkip to main contentSkip to account menu

Advagraf

Known as: Avagraf 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Background With effective agents available to prevent posttransplantation acute organ rejection, medication adherence becomes a… 
Highly Cited
2011
Highly Cited
2011
Backgrounds. Variability of blood trough concentration (C0) in immunosuppressant leads to rejection and graft loss after kidney… 
Highly Cited
2011
Highly Cited
2011
AIM To investigate the differences in the pharmacokinetics of Prograf and the prolonged release formulation Advagraf and to… 
Highly Cited
2011
Highly Cited
2011
van Hooff JP, Alloway RR, Trunečka P, Mourad M. Four‐year experience with tacrolimus once‐daily prolonged release in patients… 
Review
2011
Review
2011
Background. Advagraf is a slow release form of tacrolimus with once-daily formulation. The potential advantages of Advagraf are… 
Highly Cited
2010
Highly Cited
2010
This multicenter, 1:1‐randomized, parallel‐group, noninferiority study compared the efficacy and safety of twice‐daily tacrolimus… 
Highly Cited
2010
Highly Cited
2010
The efficacy and safety of dual‐therapy regimens of twice‐daily tacrolimus (BID; Prograf) and once‐daily tacrolimus (QD; Advagraf…